2 Firms Steer Biotech Firm's $425M Merger With US Rival
Redx Pharma, a British biotechnology company, and U.S. rival Jounce Therapeutics announced on Thursday that they intend to merge and create a $425 million pharmaceutical giant, in a deal guided by Cooley...To view the full article, register now.
Already a subscriber? Click here to view full article